In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes

Drug Metabolism and Disposition

Volumn 34, Issue 1, 2006, Pages 176-183

  Cho, Taehyeon M ^a   Rose, Randy L ^a   Hodgson, Ernest ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHOL; 1,4 NAPHTHOQUINONE; 1,7 NAPHTHALENEDIOL; 2 NAPHTHOL; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 3A4; LIVER ENZYME; NAPHTHALENE; NAPHTHALENE DERIVATIVE; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVITY; ENZYME SUBSTRATE; ENZYME SYNTHESIS; HUMAN; LIVER MICROSOME METABOLISM; PRIORITY JOURNAL; SCREENING;

CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; ISOENZYMES; KINETICS; MICROSOMES, LIVER; MOLECULAR STRUCTURE; NAPHTHALENES; NAPHTHOQUINONES;

EID: 29944447220     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.105.005785     Document Type: Article

References (32)

1. Bagchi D, Balmoori J, Bagchi M, Ye X, Williams CB, and Stohs SJ (2000) Role of p53 tumor suppressor gene in the toxicity of TCDD, endrin, naphthalene and chromium (VI) in liver and brain tissues of mice. Free Radic Biol Med 28:895-903.
2. Bagchi M, Bagchi D, Balmoori J, Ye X, and Stohs SJ (1998) Naphthalene-induced oxidative stress and DNA damage in cultured macrophage J774A. 1 cells. Free Radic Biol Med 25:137-143.
3. Buckpitt A, Boland B, Isbell M, Morin D, Shultz M, Baldwin R, Chan K, Karlsson A, Lin C, Taff A, et al. (2002) Naphthalen-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metab Rev 34:791-820.
4. Buckpitt A, Chang AM, Weir A, Van Winkle L, Duan X, Philpot R, and Plopper C (1995) Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats and hamsters. Mol Pharmacol 47:74-81.
5. Buckpitt AR and Bahnson LS (1986) Naphthalene metabolism by human lung microsomal enzymes. Toxicology 41:333-341.
6. Buckpitt AR, Bahnson LS, and Franklin RB (1984) Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation. J Pharmacol Exp Ther 231:291-300.
7. Buckpitt AR, Castagnoli N, Nelson SD, Jones AD, and Bahnson LS (1987) Stereo-selectivity of naphthalene epoxidation by mouse, rat, and hamster pulmonary, hepatic and renal microsomal enzymes. Drug Metab Dispos 15:491-498.
8. Chichester CH, Buckpitt AR, Chang A, and Plopper CG (1994) Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells. Mol Pharmacol 45:664-672.
9. Doherty MD, Cohen GM, and Smith MT (1984) Mechanisms of toxic injury to isolated hepatocytes by 1-naphthol. Biochem Pharmacol 33:543-549.
10. Elovaara E, Väänänen V, and Mikkola J (2003) Simultaneous analysis of naphthols, phenanthrols and 1-hydroxypyrene in urine as biomarkers of polycyclic aromatic hydrocarbon exposure: intraindividual variance in the urinary metabolite excretion profiles caused by intervention with β-naphthoflavone induction in the rat. Arch Toxicol 77:183-193.
11. 14C]1-naphthol formed by rat liver microsomes. Mol Pharmacol 16:667-675.
12. Lee C-Y, Lee J-Y, Kang J-W, and Kim H (2001) Effects of genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on the urinary levels of 1-hydroxypyrene and 2-naphthol in aircraft maintenance workers. Toxicol Lett 123:115-124.
13. McDougal JN, Pollard DL, Weisman W, Garrett CM, and Miller TE (2000) Assessment of skin absorption and penetration of JP-8 jet fuel and its components. Toxicol Sci 55:247-255.
14. Morisseau C and Hammock BD (2005) Epoxide hydrolases: mechanisms, inhibitor designs and biological roles. Annu Rev Pharmacol Toxicol 45:311-333.
15. Pakenham G, Lango J, Buonarati M, Morin D, and Buckpitt A (2002) Urinary naphthalene mercapturates as biomarkers of exposure and stereoselectivity of naphthalene epoxidation. Drug Metab Dispos 30:247-253.
16. Penning TM, Burczynski ME, Hung C-F, McCoull KD, Palackal NT, and Tsuruda LS (1999) Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones. Chem Res Toxicol 12:1-18.
17. Plopper CG, Van Winkle LS, Fanucchi MV, Malburg SRC, Nishio SJ, Chang A, and Buckpitt AR (2001) Early events in naphthalene-induced acute Clara cell toxicity II. Comparison of glutathione depletion and histopathology by airway location. Am J Respir Cell Mol Biol 24:272-281.
18. Preuss R, Angerer J, and Drexler H (2003) Naphthalene - an environmental and occupational toxicant. Int Arch Occup Environ Health 76:556-576.
19. Riviere JE, Brooks JD, Monteiro-Riviere NA, Budsaba K, and Smith CE (1999) Dermal absorption and distribution of topically dosed jet fuels Jet-A, JP-8 and JP-8(100). Toxicol Appl Pharmacol 160:60-75.
20. Rodrigues AD (1999) Integrated cytochrome P450 reaction phenotyping. Attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. Biochem Pharmacol 57:465-480.
21. Shealy DB, Barr JR, Ashley DL, Patterson DG Jr, Camann DE, and Bond AE (1997) Correlation of environmental carbaryl measurements with serum and urinary 1-naphthol measurements in a farmer applicator and his family. Environ Health Perspect 105:510-513.
22. Shimada T, Yamazaki H, Mimura M, Inui Y, and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
23. Smart G and Buckpitt AR (1983) Formation of reactive naphthalene metabolites by target vs non-target tissue microsomes: methods for the separation of three glutathione adducts. Biochem Pharmacol 32:943-946.
24. Stohs SJ, Ohia S, and Bagchi D (2002) Naphthalene toxicity and antioxidant nutrients. Toxicology 180:97-105.
25. Tingle MD, Pirmohamed M, Templeton E, Wilson AS, Madden S, Kitteringham NR, and Park BK (1993) An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes. Biochem Pharmacol 46:1529-1538.
26. Van Bladeren PJ, Vyas KP, Sayer JM, Ryan DE, Thomas PE, Levin W, and Jerina DM (1984) Stereoselectivity of cytochrome P-450c in the formation of naphthalene and anthracene 1,2-oxides. J Biol Chem 259:8966-8973.
27. Van Winkle LS, Gunderson AD, Shimizu JA, Baker GL, and Brown CD (2002) Gender differences in naphthalene metabolism and naphthalene-induced acute lung injury. Am J Physiol 282:L1122-L1134.
28. Van Winkle LS, Johnson ZA, Nishio SJ, Brown CD, and Plopper CG (1999) Early events in naphthalene-induced acute Clara cell toxicity. Comparison of membrane permeability and ultrastructure. Am J Respir Cell Mol Biol 21:44-53.
29. Vuchetich PJ, Bagchi D, Bagchi M, Hassoun EA, Tang L, and Stohs SJ (1996) Naphthalene-induced oxidative stress in rats and the protective effects of vitamin E succinate. Free Radic Biol Med 21:577-590.
30. White RD (1999) Refining and blending of aviation turbine fuels. Drug Chem Toxicol 22:143-153.
31. Wilson AS, Davis CD, Williams DP, Buckpitt AR, Pirmohamed M, and Park BK (1996) Characterization of the toxic metabolite(s) of naphthalene. Toxicology 114:233-242.
32. Yang M, Koga M, Katoh T, and Kawamoto T (1999) A study for the proper application of urinary naphthols, new biomarkers for airborne polycyclic aromatic hydrocarbons. Arch Environ Contam Toxicol 36:99-108.